相关实验视频

Updated: Jun 14, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

新型氨基酶A抑制剂的合理设计,合成和药理学表征

Fabrice Balavoine1, Delphine Compere2, Frédéric Miege3

  • 1Quantum Genomics, 6 rue Cambacérès, F-75008 Paris, France.

Bioorganic & medicinal chemistry letters
|September 5, 2024
PubMed
概括

研究人员开发出了一种强大且有选择性的阿米诺酶A (APA) 抑制剂,该酶是大脑氨酸- ангиотензин系统中的关键酶. 这一发现为治疗高血压和心力衰竭提供了一个有前途的新治疗途径.

关键词:
氨基酸酶A是一种氨基酸酶.氨基酸氨基酸是一种氨基酸.这是一种金属蛋白酶抑制剂.雷宁 - ангиотензин 系统结构与活动之间的关系.

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

470
Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

18.1K

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
679